Probing interactions between HIV-1 reverse transcriptase and its DNA substrate with backbone-modified nucleotides. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Probing interactions between HIV-1 reverse transcriptase and its DNA substrate with backbone-modified nucleotides.

Chem Biol. 1999 Feb;6(2):111-6. Unique Identifier : AIDSLINE MED/99147129
Marx A; Spichty M; Amacker M; Schwitter U; Hubscher U; Bickle TA; Maga G; Giese B; Department of Chemistry, University of Basel, Switzerland.


Abstract: BACKGROUND: To gain a molecular understanding of a biochemical process, the crystal structure of enzymes that catalyze the reactions involved is extremely helpful. Often the question arises whether conformations obtained in this way appropriately reflect the reactivity of enzymes, however. Rates that characterize transitions are therefore compulsory experiments for the elucidation of the reaction mechanism. Such experiments have been performed for the reverse transcriptase of the type 1 human immunodeficiency virus (HIV-1 RT). RESULTS: We have developed a methodology to monitor the interplay between HIV-1 RT and its DNA substrate. To probe the protein-DNA interactions, the sugar backbone of one nucleotide was modified by a substituent that influenced the efficiency of the chain elongation in a characteristic way. We found that strand elongation after incorporation of the modified nucleotide follows a discontinuous efficiency for the first four nucleotides. The reaction efficiencies could be correlated with the distance between the sugar substituent and the enzyme. The model was confirmed by kinetic experiments with HIV-1 RT mutants. CONCLUSIONS: Experiments with HIV-1 RT demonstrate that strand-elongation efficiency using a modified nucleotide correlates well with distances between the DNA substrate and the enzyme. The functional group at the modified nucleotides acts as an 'antenna' for steric interactions that changes the optimal transition state. Kinetic experiments in combination with backbone-modified nucleotides can therefore be used to gain structural information about reverse transcriptases and DNA polymerases.
Keywords: JOURNAL ARTICLE Acetylation Crystallization DNA/CHEMISTRY/GENETICS/*METABOLISM DNA-Directed DNA Polymerase/METABOLISM Human HIV-1 Reverse Transcriptase/GENETICS/*METABOLISM Kinetics Mutation Nucleotides/CHEMISTRY Peptide Chain Elongation Protein Conformation Support, Non-U.S. Gov'tKWDjournalarticleacetylationcrystallizationdna/chemistry/genetics/KWDmetabolismdna-directeddnapolymerase/metabolismhumanhiv-1reversetranscriptase/genetics/KWDmetabolismkineticsmutationnucleotides/chemistrypeptidechainelongationproteinconformationsupport,non-uKWDsKWDgov't
990630
A9960959

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .